|
CURIA，前身为Albany Molecular Research, Inc. (AMRI)，成立于1991年，是一家全球性的合同研究、开发和制造组织（CDMO）。CURIA提供覆盖药物开发全谱的产品和服务，帮助合作伙伴将其想法转化为现实，从而提高商业绩效并改善患者生活。CURIA通过其在北美、欧洲和亚洲的分支机构，为全球的制药和生物技术公司提供支持。CURIA拥有深厚的科研和技术专长，提供包括生物学研究、化学过程研发、临床生产、配方开发等多方面服务。通过不断的技术创新和市场扩展，CURIA已成为生命科学领域的重要参与者。
CURIA, formerly known as Albany Molecular Research, Inc. (AMRI), founded in 1991, is a global contract research, development, and manufacturing organization (CDMO). CURIA offers a broad range of products and services across the entire drug development spectrum to assist partners in transforming their ideas into reality, thereby enhancing business performance and improving patients' lives. With branches in North America, Europe, and Asia, CURIA supports pharmaceutical and biotechnology companies worldwide. Boasting profound research and technical expertise, CURIA provides various services including biology research, chemical process R&D, clinical production, and formulation development. Through continuous technological innovation and market expansion, CURIA has become an important player in the life sciences field.
|
|